FLEURY S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.67 BRL | +4.71% |
|
-0.54% | -18.68% |
| May. 10 | Fleury Seeks Acquisitions | CI |
| May. 10 | Transcript : Fleury S.A., Q1 2024 Earnings Call, May 10, 2024 |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 7.84B 1.53B | Sales 2025 * | 8.34B 1.63B | Capitalization | 8B 1.56B |
|---|---|---|---|---|---|
| Net income 2024 * | 627M 122M | Net income 2025 * | 774M 151M | EV / Sales 2024 * | 1.49 x |
| Net Debt 2024 * | 3.7B 721M | Net Debt 2025 * | 3.22B 628M | EV / Sales 2025 * | 1.34 x |
| P/E ratio 2024 * |
13
x | P/E ratio 2025 * |
10.5
x | Employees | 27,300 |
| Yield 2024 * |
4.22% | Yield 2025 * |
5.2% | Free-Float | 43.97% |
More Fundamentals
* Assessed data
More news
Latest transcript on Fleury S.A.
More press releases
| 1 day | +4.71% | ||
| 1 week | -0.54% | ||
| Current month | +1.31% | ||
| 1 month | +4.49% | ||
| 3 months | -7.62% | ||
| 6 months | -14.66% | ||
| Current year | -18.68% |
1 week
14.31
14.85
1 month
13.6915.07
Current year
13.6918.08
1 year
13.6918.96
3 years
12.8926.55
5 years
12.8932.47
10 years
6.1032.47
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 00-12-31 | |
| Director of Finance/CFO | 63 | 21-07-22 | |
| Chief Tech/Sci/R&D Officer | 48 | 06-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | - | |
| Director/Board Member | 78 | 13-04-08 | |
João Teixeira
BRD | Director/Board Member | 58 | 21-04-29 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.43% | 2 M€ | -14.14% | ||
| 0.24% | 14 M€ | -1.29% | ||
| 0.02% | 4 M€ | -4.41% | - | |
| 0.01% | 112 M€ | +5.51% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-16 | 14.67 | +2.23% | 3,161,200 |
| 24-05-15 | 14.35 | -2.11% | 2,359,000 |
| 24-05-14 | 14.66 | +1.31% | 2,825,200 |
| 24-05-13 | 14.47 | +0.14% | 2,195,500 |
| 24-05-10 | 14.45 | -2.03% | 2,516,500 |
Delayed Quote Sao Paulo, May 16, 2024 at 04:07 pm EDT
More quotes
Fleury S.A. specializes in clinical diagnosis, treatment and analysis services.
At the end of 2018, the group operated a network of 187 patient care centers and 23 hospital centers under Fleury, Weinmann, Clínica Felipe Mattoso, a +, Labs a + and Diagnoson a + brands.
Calendar
2024-06-04
- Bradesco BBI London Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
14.35
BRL
Average target price
19.33
BRL
Spread / Average Target
+34.73%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -18.68% | 1.53B | |
| -15.71% | 8.57B | |
| +65.60% | 4.3B | |
| -9.46% | 2.47B | |
| -2.16% | 2.46B | |
| -44.11% | 2.31B | |
| -7.42% | 1.93B | |
| -41.75% | 1.2B | |
| +11.31% | 1.14B | |
| +16.15% | 986M |
- Stock Market
- Equities
- FLRY3 Stock
